Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Pliant Therapeutics Inc Is A Clinical-Stage Biopharmaceutical Company Engaged In The Discovery And Development Of Integrin-Based Therapies. The Company Operates As A Single Reportable Segment Focused On Developing And Commercializing Novel Integrin-Based Treatments. Its Lead Product Candidate, Pln-101095, Is An Oral Small Molecule Targeting Integrins For The Treatment Of Solid Tumors. The Company Also Advances A Pipeline Of Integrin-Based Programs Across Multiple Disease Areas Through Its Proprietary Drug Discovery Platform.